C-Section bleeding breakthrough? new study tests topical TXA
NCT ID NCT07362992
First seen Jan 24, 2026 · Last updated May 11, 2026 · Updated 17 times
Summary
This study tests if applying tranexamic acid (TXA) directly to the uterus during a planned C-section can reduce surgical bleeding. About 112 women having their first or second C-section will be randomly assigned to receive either TXA or a placebo. The main goal is to see if TXA shortens the time needed to close the uterus and reduces the need for extra stitches to stop bleeding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CESAREAN DELIVERY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Edith Wolfson Medical Center
Holon, Central District, 5834468, Israel
Contact Phone: •••-•••-••••
-
Kaplan medical center
Rehovot, Israel
-
Meir medical center
Kfar Saba, Israel
-
Rabin medical center
Petah Tikva, Israel
Conditions
Explore the condition pages connected to this study.